The price of Akero Therapeutics Inc (NASDAQ: AKRO) closed at $27.30 in the last session, up 14.23% from day before closing price of $23.90. In other words, the price has increased by $+3.40 from its previous closing price. On the day, 1283755 shares were traded.
Ratios:
We take a closer look at AKRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 20.25 and its Current Ratio is at 20.25. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on September 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.
Morgan Stanley Upgraded its Equal-Weight to Overweight on January 27, 2023, whereas the target price for the stock was revised from $40 to $65.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 27 when Young Jonathan sold 5,414 shares for $24.00 per share. The transaction valued at 129,936 led to the insider holds 185,131 shares of the business.
Cheng Andrew sold 1,628 shares of AKRO for $33,797 on Dec 14. The President and CEO now owns 550,911 shares after completing the transaction at $20.76 per share. On Dec 14, another insider, White William Richard, who serves as the Chief Financial Officer of the company, sold 611 shares for $20.76 each. As a result, the insider received 12,684 and left with 50,354 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1.52B and an Enterprise Value of 991.82M.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.38, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 22.14, while the 200-Day Moving Average is calculated to be 33.80.
Shares Statistics:
According to the various share statistics, AKRO traded on average about 1.10M shares per day over the past 3-months and 1.18M shares per day over the past 10 days. A total of 55.71M shares are outstanding, with a floating share count of 47.91M. Insiders hold about 14.00% of the company’s shares, while institutions hold 102.55% stake in the company. Shares short for AKRO as of Jan 31, 2024 were 7.76M with a Short Ratio of 7.03, compared to 7.37M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 13.94% and a Short% of Float of 14.32%.
Earnings Estimates
The company has 8 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.86 for the current quarter, with a high estimate of -$0.67 and a low estimate of -$1.09, while EPS last year was -$0.49. The consensus estimate for the next quarter is -$0.9, with high estimates of -$0.79 and low estimates of -$0.99.
Analysts are recommending an EPS of between -$2.66 and -$3.12 for the fiscal current year, implying an average EPS of -$2.84. EPS for the following year is -$3.53, with 8 analysts recommending between -$2.79 and -$4.29.
